0001683168-22-002865.txt : 20220421
0001683168-22-002865.hdr.sgml : 20220421
20220421214238
ACCESSION NUMBER: 0001683168-22-002865
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220421
FILED AS OF DATE: 20220421
DATE AS OF CHANGE: 20220421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thramann Jeffrey John
CENTRAL INDEX KEY: 0001846997
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41358
FILM NUMBER: 22843141
MAIL ADDRESS:
STREET 1: 8580 STRAWBERRY LANE
CITY: NIWOT
STATE: CO
ZIP: 80503
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclarion, Inc.
CENTRAL INDEX KEY: 0001635077
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 MARINERS ISLAND BLVD
STREET 2: STE 300
CITY: SAN MATEO
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650 241 1740
MAIL ADDRESS:
STREET 1: 951 MARINERS ISLAND BLVD
STREET 2: STE 300
CITY: SAN MATEO
STATE: CA
ZIP: 94404
FORMER COMPANY:
FORMER CONFORMED NAME: Nocimed, Inc.
DATE OF NAME CHANGE: 20150226
3
1
ownership.xml
X0206
3
2022-04-21
0
0001635077
Aclarion, Inc.
ACON
0001846997
Thramann Jeffrey John
C/O ACLARION, INC.
951 MARINERS ISLAND BLVD., SUITE 300
SAN MATEO
CA
94404
1
1
0
0
Executive Chairman
Employee Stock Option (right to buy)
1.94
2031-09-27
Common Stock
1204819
D
The shares under this option became fully vested at the April 21, 2022 effective time of the Company's initial public offering.
/s/ Jeffrey Thramann
2022-04-21